2014/11

Obtained CE Mark approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」

/by

2014/07

Obtained GMP certification for the manufacturing facility via TFDA

/by

2013/11

Completed prototyping of IOL and its delivery system

/by

2013/06

Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs

/by

2013/04

Obtained certification of ISO 9001/13485 Quality Management Systems

/by

2012/10

Received supplementary for the project of 「Development of High Value Aspheric Intraocular Lens and Its Delivery System for Cataract Surgery」from the Ministry of Economic Affairs

/by

2012/09

IOL manufacturing technology successfully transferred from MBI (Millennium Biomedical, Inc., USA)

/by

2012/06

Received a grant from the R&D Piloting Cooperation Projects between Industries and Academia at the Hsinchu Science Park for the project of 「Development of novel drug eluting intraocular lens」

/by

2012/06

Approved as a biotech and pharma company officially by the Ministry of Economic Affairs

/by

2012/02

Granted certificate from the Public Health Bureau to manufacture medical devices

/by